Detalhe da pesquisa
1.
The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.
Eur J Pharmacol
; 723: 207-15, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24309217
2.
A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
Eur J Pharmacol
; 696(1-3): 194-202, 2012 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23022337